Option Care Health (NASDAQ:OPCH) was upgraded by equities researchers at TheStreet from a “c+” rating to a “b” rating in a report issued on Thursday, TheStreetRatingsTable reports.
Other equities analysts also recently issued research reports about the company. Deutsche Bank Aktiengesellschaft raised their price target on Option Care Health from $23.50 to $32.00 and gave the stock a “buy” rating in a research report on Friday, November 5th. Zacks Investment Research downgraded Option Care Health from a “buy” rating to a “hold” rating in a research report on Tuesday, November 9th. Finally, Lake Street Capital lifted their price objective on Option Care Health from $27.00 to $35.00 and gave the company a “buy” rating in a research report on Monday, August 30th. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, Option Care Health presently has a consensus rating of “Buy” and a consensus target price of $27.75.
Option Care Health stock opened at $25.70 on Thursday. The company has a debt-to-equity ratio of 1.02, a quick ratio of 1.28 and a current ratio of 1.67. The stock has a fifty day moving average of $25.82 and a two-hundred day moving average of $23.30. The company has a market capitalization of $4.62 billion, a price-to-earnings ratio of 55.87 and a beta of 1.33. Option Care Health has a fifty-two week low of $14.31 and a fifty-two week high of $28.59.
Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Thursday, November 4th. The company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.01. The company had revenue of $891.94 million during the quarter, compared to the consensus estimate of $886.47 million. Option Care Health had a return on equity of 7.86% and a net margin of 2.48%. Option Care Health’s revenue was up 14.1% compared to the same quarter last year. During the same quarter last year, the business posted $0.01 earnings per share. On average, analysts forecast that Option Care Health will post 0.6 EPS for the current fiscal year.
In related news, COO Harriet Booker sold 6,000 shares of Option Care Health stock in a transaction on Monday, December 6th. The stock was sold at an average price of $24.81, for a total value of $148,860.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 47.00% of the stock is owned by insiders.
Institutional investors have recently modified their holdings of the stock. Royal Bank of Canada lifted its stake in shares of Option Care Health by 86.4% during the first quarter. Royal Bank of Canada now owns 13,278 shares of the company’s stock worth $235,000 after purchasing an additional 6,153 shares in the last quarter. Principal Financial Group Inc. lifted its stake in shares of Option Care Health by 19.7% during the first quarter. Principal Financial Group Inc. now owns 59,101 shares of the company’s stock worth $1,048,000 after purchasing an additional 9,723 shares in the last quarter. Alliancebernstein L.P. lifted its stake in shares of Option Care Health by 9.3% during the second quarter. Alliancebernstein L.P. now owns 129,900 shares of the company’s stock worth $2,841,000 after purchasing an additional 11,100 shares in the last quarter. Trustcore Financial Services LLC lifted its stake in shares of Option Care Health by 33.3% during the second quarter. Trustcore Financial Services LLC now owns 2,000 shares of the company’s stock worth $44,000 after purchasing an additional 500 shares in the last quarter. Finally, Advisor Group Holdings Inc. lifted its stake in shares of Option Care Health by 110.0% during the second quarter. Advisor Group Holdings Inc. now owns 3,561 shares of the company’s stock worth $78,000 after purchasing an additional 1,865 shares in the last quarter. Hedge funds and other institutional investors own 79.03% of the company’s stock.
About Option Care Health
Option Care Health, Inc engages in the provision of home and alternate site infusion services. The firm involves in the clinical management of infusion therapy, nursing support, and care coordination. It also offers anti-infective, nutrition support, heart failure, chronic inflammatory disorders, immunoglobulin, bleeding disorders, women’s health, neurological disorders, and specialized therapies.